PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
29-Aug-2018 PolarityTE, Inc. to Participate in Several Upcoming Healthcare Conferences PolarityTE, Inc.
29-Aug-2018 Sophiris Bio Updates on Phase 2b Localized Prostate Cancer Trial Sophiris Bio Inc.
29-Aug-2018 Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia Impel NeuroPharma
29-Aug-2018 Audentes Therapeutics to Participate in Upcoming Investor Conferences Audentes Therapeutics, Inc.
29-Aug-2018 Aevi Genomic Medicine to Present at the H.C. Wainwright 20th Annual Global Investment Conference Aevi Genomic Medicine, Inc.
29-Aug-2018 Berkeley Lights Appoints Dr. Michel Sadelain To Strategic Scientific Advisory Board Berkeley Lights, Inc.
29-Aug-2018 Check-Cap Announces Participation at the 20th Annual Rodman & Renshaw Global Investment Conference Check-Cap Ltd.
29-Aug-2018 Tongue Tie and Lip Tie Treated with Gentle Laser Frenectomy in Sarasota, FL by Pediatric Dentist, Dr. Maribel Santos-Cordero Dr. Maribel Santos-Cordero
29-Aug-2018 MEI Pharma To Present at Wells Fargo Securities 2018 Healthcare Conference MEI Pharma, Inc.
29-Aug-2018 PatSnap introduces sequence searching with launch of PatSnap Bio PatSnap
29-Aug-2018 Ningxia Sustainability Summit Held Successfully in Yinchuan, Ningxia, China China Global Philanthropy Institute
29-Aug-2018 Soligenix to Present at the 2018 ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Soligenix, Inc.
29-Aug-2018 Almac Group Appoints New Site Head for Charnwood Campus, Loughborough, UK Almac Group
29-Aug-2018 Ozempic® consistently reduced the risk of major cardiovascular events across type 2 diabetes populations at high CV risk regardless of prior CV events at baseline Novo Nordisk
29-Aug-2018 Cherwell supports conference addressing challenges in aseptic manufacturing of advanced medicinal therapeutics Cherwell
29-Aug-2018 GW Pharmaceuticals presents latest cannabidiol oral solution (CBD) data at the 13th European Congress of Epileptology GW Pharmaceuticals
29-Aug-2018 The Institute of Cancer Research, London, is issuing the following statement in response to the draft decision by NICE not to recommend CAR T-cell therapy for two types of non-Hodgkin lymphoma. The Institute of Cancer Research
29-Aug-2018 YESCARTA® (AXICABTAGENE CILOLEUCEL) RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR THE TREATMENT OF RELAPSED OR REFRACTORY DLBCL AND PMBCL, AFTER TWO OR MORE LINES OF SYSTEMIC THERAPY Kite
29-Aug-2018 New data from real world evidence indicates need for better secondary prevention to reduce long-term ischaemic risk in heart attack survivors AstraZeneca
29-Aug-2018 Congenica Appoints Wendy Britten as Chief Financial Officer Congenica